Ensign Peak Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $265K | Sell |
|
|||||
|
2024
Q4 | $4.27M | Buy |
|
|||||
|
2024
Q3 | $700K | Hold |
|
|||||
|
2024
Q2 | $598K | Buy |
|
|||||
|
2024
Q1 | $975K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $2.41M | Buy |
|
|||||
|
2022
Q2 | $1.62M | Buy |
|
|||||
|
2022
Q1 | $474K | Sell |
|
|||||
|
2021
Q4 | $4.84M | Buy |
|
|||||
|
2021
Q3 | $4.78M | Buy |
|
|||||
|
2021
Q2 | $960K | Hold |
|
|||||
|
2021
Q1 | $1.17M | Sell |
|
|||||
|
2020
Q4 | $1.78M | Sell |
|
|||||
|
2020
Q3 | $1.28M | Buy |
|
|||||
|
2020
Q2 | $753K | Hold |
|
|||||
|
2020
Q1 | $821K | Buy |
|
|||||
|
2019
Q4 | $558K | Buy |
|